Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Patient Derived Preclinical Models

for
Cancer
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05324553

Recruiting

Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver

for
Colorectal Cancer, Metastatic Cancer
Location: Goshen IN
Sponsor: Goshen Health System

Sex: All

Age: 18+

Code: NCT00408551

Phase 2, Recruiting

Exercise and Movement to Enhance Resiliency in Cancer Patients

for
Gynecologic Cancer
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: Female

Age: 18+

Code: NCT06809933

Recruiting

The Radiation Oncology Registry and Biosample Repository

for
Neoplasia
Location: Voorhees Township NJ, Philadelphia PA, Lancaster PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT01577251

Recruiting

Advancing Cancer Control Engaged Research Through Transformative Solutions (ACCERT) Social Determinants of Health (SDoH) Navigation Program

for
Cancer, Cancer , Healthy
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT07669753

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

for
Metastatic Hepatocellular Carcinoma, Solid Tumors,
Location: Boston MA, New York NY, Baltimore MD, Toronto,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06915753

Phase 1, Recruiting

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

for
Endocrine Tumors, Thyroid Neoplasms, Parathyroid Neoplasms,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 4+

Code: NCT01005654

Recruiting

PediRISE Feasibility

for
Pediatric Cancer, Financial Stress, Financial Hardship,
Location: Boston MA, New York NY, San Francisco CA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 0 - 17

Code: NCT06283251

Recruiting

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

for
Solid Tumor, Adult
Location: Los Angeles CA
Sponsor: BioInvent International AB

Sex: All

Age: 18+

Code: NCT04219254

Phase 1, Phase 2, Recruiting

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Boston MA, New York NY, Baltimore MD,
Sponsor: Nuvalent Inc.

Sex: All

Age: 18+

Code: NCT06521554

Phase 1, Recruiting

CANnabinoids in Pediatric ONCology

for
Childhood Cancer, Cancer
Location: Halifax, Toronto, Vancouver
Sponsor: University of Manitoba

Sex: All

Age: 4 - 18

Code: NCT05754840

Phase 1, Phase 2, Recruiting

A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors

for
Solid Tumor
Location: Dallas TX
Sponsor: Abbisko Therapeutics Co, Ltd

Sex: All

Age: 18+

Code: NCT05244551

Phase 1, Recruiting

Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples

for
Breast Cancer, Ovarian Cancer, Gynecologic Cancers,
Location: Stanford CA
Sponsor: Stanford University

Sex: Female

Age: 18+

Code: NCT01034033

Recruiting

IMPACT: IMplementation of Physical Activity for Children and Adolescents on Treatment

for
Pediatric Cancer, Pediatric Hematology
Location: Edmonton, Calgary
Sponsor: University of Calgary

Sex: All

Age: 5 - 18

Code: NCT04956133

Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors, Colorectal Cancer
Location: New Brunswick NJ, Toronto, Atlanta GA, Ann Arbor MI,
Sponsor: Vividion Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06004245

Phase 1, Recruiting

A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Providence RI, New York NY, Fairfax VA, Toronto,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT05765851

Phase 1, Recruiting

Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors

for
Advanced Refractory Solid Tumors,
Location: New Haven CT, Ohio City OH, Michigan Center MI,
Sponsor: Cosmo Technologies Ltd

Sex: All

Age: 18+

Code: NCT03863145

Early Phase 1, Recruiting

Bromelain, Comosain as a New Drug for Treating and Preventing Various Types of Cancer in the Humans

for
Cancer
Location: West Covina CA
Sponsor: Oeyama-Moto Cancer Research Foundation

Sex: All

Age: 18 - 70+

Code: NCT02340845

Phase 2, Recruiting

Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE)

for
Cancer
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: Female

Age: 18+

Code: NCT07454499

Recruiting

Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced Malignancies

for
Advanced Malignancies
Location: New York NY, Fairfax VA, Houston TX, Irving TX,
Sponsor: PharmaMar

Sex: All

Age: 18+

Code: NCT07644039

Phase 1, Phase 2, Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial